ReviewNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Heterogeneity of monogenic epilepsy in loci, phenotypes, and treatment approaches.
Review in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundMonogenic epilepsies are a group of rare disorders that manifest in early childhood and are usually associated with neurodevelopmental abnormalities and poor drug response. The field of genetic epilepsy is continuously evolving in alignment with the vast advancements in genetic testing in the last decade.
methodsRecent studies and databases were reviewed to explore the latest updates in monogenic epilepsies.
findingsThis literature review reveals the remarkable progress in understanding monogenic epilepsy classification, genetic aetiologies, and treatment over the past decade. The International League Against Epilepsy classification system continues to evolve, providing increasingly precise diagnostic frameworks that incorporate genetic and etiologic information. The genetic landscape of epilepsy has expanded dramatically, with around 2000 genes now associated with seizures and/ or epilepsy pertaining to complex and overlapping neuronal networks. Besides the locus heterogeneity, monogenic epilepsy phenotypes exhibit phenotypic variabilities due to differences in pathogenic causative variants as well as unique genetic backgrounds in affected individuals. Identification of the underlying molecular aetiology permits personalized management approaches which are currently limited approved agents. Genes encoding antiepileptic drug targets, metabolic enzymes and transporters are additionally implicated in the precision medicine.
conclusionCurrent knowledge in Locus heterogeneity should be addressed in epilepsy phenotypes to avoid extensive diagnostic delays particularly in cases that can be rescued with available management options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.